With this case study, you will learn how Almac and its newest generation IRT, IXRS® 3, has helped a prominent trial sponsor accommodate FDA requirements on a pivotal, global, and multi-lingual trial.
You’ll discover:
Ways to avoid postponing the study start
Tips for remaining in full compliance with FDA requirements
